Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.
crisnatol mesylate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryFourteen patients with advanced ovarian cancer received a 72 hour infusion of a new DNA intercalator, crisnatol mesylate… Expand
Is this relevant?
1999
1999
This Phase I and pharmacological study was performed to assess the feasibility of administering the polycyclic aromatic… Expand
Is this relevant?
1997
1997
A total of 26 patients (6 with anaplastic astrocytoma; 20 with glioblastoma) were treated with crisnatol mesylate. All patients… Expand
Is this relevant?
1992
1992
Microbial metabolism studies of crisnatol (1), a new DNA interca-lator, has resulted in the isolation and characterization of a… Expand
Is this relevant?
1991
1991
SummaryCrisnatol mesylate is a rationally designed cytotoxic arylmethylamino-propanediol with broad spectrum cytotoxic activity… Expand
Is this relevant?
1990
1990
The pharmacodynamics of a new series of antitumor DNA intercalators, known as arylmethylaminopropanediols (AMAPs), has been… Expand
Is this relevant?